A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib.

Ling Peng Kui Xiao Silvia Ottaviani Justin StebbingYing-Jie Wang

Published in: Expert opinion on drug safety (2020)

The incidence of these AEs does not appear above the background expected. These data are consistent with routine clinical observations and suggest the importance of pharmacovigilance.

Keyphrases

adverse drug
electronic health record
risk factors
clinical practice
big data
emergency department
drug induced
machine learning
data analysis
drug administration